MiMARK
Mimark develops protein-based diagnostics to diagnose gynecological diseases from a simple, minimally invasive fluid sample.
$4.9M Seed ·
Source: Dealroom
All 2 rounds ↓About MiMARK
Simpler, safer, more human.
Funding rounds
- Seed · $4.9MSource: Dealroom
- Seed · amount undisclosedSource: fundraisingfox.com
Founders and team
MR
Marina Rigau CEO & Foundersource: mimark.esAG
Antonio Gil CMO & Foundersource: mimark.esEC
Eva Colás CSO & Foundersource: mimark.es
Companies like MiMARK
XX-Zell
PPhase Scientific$34M Series A · May 2025
RRespiro Diagnostics$1.33M Pre Seed · Jul 2026
Yyngvi bioPre Seed · Sep 2026
GGrobioSeries A · Nov 2021UUrologic Design$1.2M Seed · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mimark (get a free API key).